Xuenou > Trending > FDA still skeptical of ALS drug ahead of high-stakes meeting
FDA still skeptical of ALS drug ahead of high-stakes meeting
The U.S. Food and Drug Administration has posted another negative review of a closely watched drug for the deadly neurodegenerative disease ALS

FDA still skeptical of ALS drug ahead of high-stakes meeting

The U.S. Food and Drug Administration has posted another negative review of a closely watched drug for the deadly neurodegenerative disease ALS